Global Times: Major infrastructure projects in Malaysia showcase vitality of BRI cooperation
'My boss said that we are targeting to finish this Gombak Station by the end of this year. That has been any about a year plus, and it will be completed,' Ridzuan, a Malaysian technical engineer, told the Global Times. Although he has been part of the construction work for months, witnessing the progress firsthand, Ridzuan appeared to be at shock when describing the goal. 'I don't know, but I think if it's another company, this could take at least two years and maybe even up to three years.'
The Gombak Station, about 30 minutes away from downtown, is one of the major stops of the East Coat Rail Link (ECRL), a landmark cooperation project between China and Malaysia under the framework of the Belt and Road Initiative (BRI). The 665-km railway is expected to be completed by the end of 2027, and once completed, will Malaysia's less-developed east coast with its economic powerhouse on the west coast, according to Xinhua.
Being built by China Communications Construction Co (CCCC), construction work of the ECRL is currently in full swing. And bustling scene at the Gombak Station offers of crucial window into the strong vitality of China-Malaysia BRI cooperation.
Rapid development
The ECRL became an important focus as the two countries aim to further upgrade bilateral ties and strengthen cooperation. In a joint statement issued on Thursday, China and Malaysia agreed to promote the implementation of the Belt and Road Initiative Cooperation Plan signed in 2024 and further synergize development strategies.
In Kuala Lumpur, locals are quick to point out the long history of exchanges between China and Malaysia that started centuries ago, and the rapid development in bilateral ties since formal diplomatic ties started over 50 years ago and Malaysia was among the first to participate in BRI cooperation.
'In the case of Malaysia, China-Malaysia engagement has a centuries-old legacy to trace… Malaysia is the first ASEAN member state building diplomatic ties with China,' Ong Tee Keat, president of the Belt and Road Initiative Caucus for Asia Pacific and a former minister of transport of Malaysia, told the Global Times. 'Bilateral ties embarked on a fast track in 2013 when Malaysia embraced the BRI.'
The rapid development in China-Malaysia BRI cooperation is vividly displayed at major projects in Malaysia. In addition to the ECRL, there are also plenty of signs of the strong vitality in BRI cooperation between China and Malaysia.
Rising 452 meters above the heart of Kuala Lumpur's Tun Razak Exchange, the Exchange 106 tower stands as one of Malaysia's tallest structures, a gleaming icon etched into the city's skyline. From the 105th floor, the vibrant panorama of Kuala Lumpur unfolds in breathtaking splendor. Yet, beyond its stunning vistas, this towering marvel serves as a prime vantage point to glimpse the deepening currents of collaboration between China and Malaysia.
The 106-story skyscraper was built by Chinese State Construction Engineering Corp (CSCEC) and the speed of construction work, which lasted about 31 months, was marveled by many locals.
'Because of the location, many people can see the daily progress of the construction, so many people actually paid great attention. And many of them think this is truly unbelievable,' Huang Yidong, vice general manager of Malaysia Main Branch of CSCEC, told the Global Times, adding that the project also involved various world-leading construction technologies.
Huang said that the Malaysia branch of CSCEC was established in 2013, the year the BRI was launched. 'We comprehensively responded to the initiative,' he said, 'personally, I feel very proud after joining the work in Malaysia over the past nine years, including the Exchange 106 tower project.'
Constant upgrading
Beyond the speed of its conduction, the Exchange 106 also provides a vantage point into the constantly upgrading of China-Malaysia cooperation. Stepping into the grand lobby of Exchange 106, a sprawling space on the right side commands attention, its bold '5G' signage glowing vividly. 'This is our 5G technology experience zone,' Pei Pei, the tower's marketing manager, told the Global Times, adding several Chinese companies, including Huawei, have rented space inside the building.
Emerging technologies are becoming a main focus of China-Malaysia collaboration. The joint statement issued on Thursday also stated that focusing on four key areas of digital economy, green economy, blue economy and tourism economy, the two sides will expand future economic cooperation. The two sides will also support the co-establishment of Belt and Road joint laboratories by universities from the two countries, according to the joint statement.
As the two countries continue to deepen BRI cooperation, there are also new emerging trends in bilateral collaboration, apart from major projects like the ECRL and the Exchange 106, thanks to deep, time-honored bonds shared by the two peoples.
On a hot Sunday afternoon with grueling heat, a group of young students in uniforms joked and laughed, while enjoying ice creams and drinks inside a drink store inside a shopping mall in Kuala Lumpur. The store's name is very familiar to many Chinese, especially students: Mixue Bingcheng - a Chinese tea drink chain known for its popular flavors and affordable prices and extensive network of stores across China, including in small towns.
For the same reason, Mixue has gained widespread popularity in the Malaysian market, with about 80 stores having been opened over the past two years or so, according to Khaw Chong Guan, a Mixue Franchisee in Kuala Lumpur.
Khaw said that another critical factor behind Mixue's rapid expansion is the cultural bonds between the two countries that make it easier for Malaysian consumers to adopt to Chinese products. 'When Chinese brands come here, we have Chinese Malaysians to communicate with them, so there is an understanding. And it's easy to bring them to the market here,' he told the Global Times.
In addition to the historical cultural ties, tangible mutual benefits are what makes the China-Malaysia cooperation successful.
At the construction site of the Gombak Station, Ridzuan was already counting the hours that could be saved from commuting when the ECRL will be completed. 'It can reduce, I think, three hours or four hours. It's good for the people actually,' he said.
View original content: https://www.prnewswire.com/news-releases/global-times-major-infrastructure-projects-in-malaysia-showcase-vitality-of-bri-cooperation-302432878.html
SOURCE Global Times
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
29 minutes ago
- Yahoo
China EV brands Zeekr, Neta inflated car sales to hit targets
STORY: Chinese electric vehicle brands Zeekr and Neta inflated sales to hit aggressive targets. That's according to documents reviewed by Reuters and interviews with dealers and buyers. Documents from recent years show both companies arranged for cars to be insured before they were sold to buyers. This enabled them to book sales early under Chinese industry car registration practices, so they could hit monthly and quarterly targets, sources said. Switch Auto Insurance and Save Today! Great Rates and Award-Winning Service Affordable Auto Insurance, Customized for You The Insurance Savings You Expect Documents show Neta used this method for over 64,000 cars - more than half of vehicles sold from January 2023 to March 2024. Meanwhile, premium EV brand Zeekr used the same method to book early sales in late 2024, Reuters interviewees said. Vehicles booked as sold before reaching a buyer are called "zero-mileage used cars" in the Chinese auto industry. The practice has emerged out of cutthroat competition for sales in the world's largest auto market. The industry faces a moment of reckoning, with state media calling out the zero-mileage car practice. Meanwhile, China's cabinet has pledged to regulate "irrational" competition.
Yahoo
an hour ago
- Yahoo
Organ Preservation Market worth $0.3 billion by 2030 with 6.8% CAGR
DELRAY BEACH, Fla., July 21, 2025 /PRNewswire/ --The global Organ Preservation Market, valued at US$0.1 billion in 2024 stood at US$0.2 billion in 2025 and is projected to advance at a resilient CAGR of 6.8% from 2025 to 2030, culminating in a forecasted valuation of US$0.3 billion by the end of the period. The organ preservation market is experiencing robust growth fueled by rising incidence of chronic diseases, organ failure, and advancements in transplantation procedures. Increasing rates of end-stage organ conditions—such as kidney, liver, and heart failure—combined with a growing global demand for transplant procedures are key factors accelerating market expansion. The aging population, more susceptible to organ dysfunction, further highlights the increasing need for effective preservation methods to maintain organ viability pre-transplantation. Technological progress in preservation techniques, including hypothermic and normothermic perfusion, is transforming the standard of care by enhancing organ function and extending preservation times. In parallel, developing innovative preservation solutions such as the University of Wisconsin (UW) solution and Custodiol HTK significantly improves transplantation outcomes. Rising awareness among healthcare providers and the public about timely organ donation and preservation is increasing product adoption. Expanding hospital transplant programs, supportive government initiatives, and improved healthcare infrastructure in emerging markets also drive market momentum. Download PDF Brochure: Browse in-depth TOC on "Organ Preservation Market" 300 - Tables 100 - Figures 400 - Pages By solution, the organ preservation market, by solution, is categorized into UW Solution, Custodial HTK, Perfadex, and other solutions (including EuroCollins and Celsior). The UW (University of Wisconsin) solution accounted for the largest market share in 2024. This solution is widely used for preserving and flushing organs such as the liver, kidneys, and pancreas. As the first intracellular solution introduced for this purpose, it has become the benchmark in organ preservation. The dominance of the UW solution can be credited to its high efficacy in improving transplant outcomes. This is primarily due to the inclusion of metabolically inactive compounds like lactobionate and raffinose, which help reduce tissue damage, maintain cellular integrity, and enhance the physiological viability of organs during storage. These advantages have made the UW solution preferred over alternative preservation media. By technique, the static cold storage segment is expected to dominate the market due to its simplicity, cost-effectiveness, and widespread use in preserving kidneys, liver, and pancreas. While newer technologies such as hypothermic machines and normothermic perfusion are gaining traction, especially for heart and lung preservation, static cold storage remains the gold standard in many transplant centers worldwide. In addition, ongoing advancements in perfusion technologies and a growing focus on organ quality optimization before transplantation are expanding the market. The increasing initiatives by governments and non-profits to promote organ donation, along with improvements in preservation solutions and transportation logistics, are further contributing to market growth. As the demand for transplantable organs continues to outpace supply, efficient and advanced preservation methods become more crucial in ensuring transplant success. By organ type, Organ preservation, categorized by organ type, includes kidneys, liver, lungs, heart, and pancreas. In 2024, the kidney segment emerged as the leading contributor to the market. This prominence is primarily due to the rising prevalence of end-stage renal disease (ESRD), for which kidney transplantation remains the most effective treatment option. As kidney failure cases continue to grow, so does the number of transplant procedures, necessitating efficient preservation of donor kidneys before implantation in recipients. By end user, the organ preservation market is divided into transplant centers, hospitals, and specialty clinics. In 2024, the organ transplant centers segment accounted for the largest share of the market. The large share of this segment can be attributed to the extensive establishment of healthcare facilities that operate dedicated transplant programs. These centers are central to organ retrieval, preservation, and transplantation, making them critical consumers of preservation products and technologies. By geography, The Asia Pacific region is projected to grow at the highest CAGR during the forecast period. The high growth rate of the Asia Pacific region is attributed to supportive government policies, rising public awareness regarding organ donation, and a surge in organ donation activities. Countries like China and Japan have implemented standardized national guidelines for organ donation and transplantation, which are playing a key role in advancing the market. Additionally, improvements in healthcare infrastructure, the increasing burden of chronic illnesses, and the rise of medical tourism across several countries in the region are expected to fuel the market growth during the forecast period. Request Sample Pages : The prominent players in the global organ preservation market are Paragonix Technologies (US), XVIVO Perfusion AB (Sweden), Dr. Franz Köhler Chemie GmbH (Germany), Essential Pharmaceuticals, LLC (US), TransMedics (US), OrganOx Limited (UK), 21st Century Medicine (US), Shanghai Genext Medical Technology (China), Bridge to Life Limited (US), Waters Medical Systems (US), Preservation Solutions (US), Carnamedica (Poland), Transplant Biomedicals (Spain), Institut Georges Lopez (France), Global Transplant Solutions (US), Avionord (Italy), Organ Preservation Solutions (England), EBERS (Spain), S.A.L.F. (Italy), Biochefa (Poland), Vascular Perfusion Solutions, Inc. (US), and TX Innovations (Netherlands). Paragonix (US): Paragonix is the leading market player in organ preservation. It operates mainly in the US and Europe. The company has been focused on developments such as new product launches, partnerships, agreements, and approvals since 2016. The company has developed devices for all thoracic & abdominal organ preservation. Paragonix also focuses on software services and tools for real-time organ tracking. Paragonix partnered with the Lung Transplant Foundation (US) to develop various technologies to improve donor lung preservation. In January 2021, the company partnered with Southwest Transplant Alliance (STA) to provide advanced organ preservation technologies. Such a development proves the company's strong market prevalence. XVIVO Perfusion AB (Sweden) XVIVO Perfusion AB is a prominent market and public domain company. It is headquartered in Sweden and operates in Europe, Asia, the Middle East, and North & South America. It spends nearly 31% of its revenue on R&D, which is why the company is involved in developing improved products for organ perfusion. XVIVO's lung perfusion solution is used mainly in Lung Preservation, making the solution a gold standard. In September 2020, XVIVO Perfusion entered an acquisition agreement with Organ Assist. This agreement further strengthened the company's product range and expanded its addressable market. Dr. Franz Kohler Chemie GmbH (Germany) Dr. Franz Kohler Chemie GmbH is a leading market player in organ preservation solutions since 1959. It involves developing electrolyte solutions, organ-protective solutions, therapeutics, antidotes, X-ray contrast agents, and medical devices. It has captured the market for Custodial, an organ preservation solution. Custodial holds advantages over other solutions, like reduced viscosity and an improved graft survival rate, and is widely used to preserve all organs, unlike other solutions. These advantages of a Custodial solution for organ preservation prove that Dr. Franz Kohler Chemie GMBH holds a substantial market prevalence. For more information, Inquire Now! Related Reports: Biopreservation Market Cardiac Monitoring & Cardiac Rhythm Management Devices Market Electrophysiology Market Human Organoids Market Transplant Diagnostics Market Get access to the latest updates on Organ Preservation Companies and Organ Preservation Market Size About MarketsandMarkets™: MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter , LinkedIn and Facebook . Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC. 1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Our Website: Logo: View original content: SOURCE MarketsandMarkets Sign in to access your portfolio
The Verge
an hour ago
- The Verge
Tesla's response to cratering sales? A deals blitz
With its sales in the crapper, Tesla is resorting to a slate of deals and incentives to get reinvigorate flagging customer interest in its lineup of electric vehicles. In recent days, the automaker has rolled out a series of discounts and financing incentives on all of its models, as it seeks to capitalize on what is likely to be its last best chance at a successful sales quarter. It's an understandable move, given how much of a drag this year has been for Tesla. The company recently reported a 14 percent drop in second quarter sales year over year. Tesla's sales in Europe have been in a serious slump with five straight consecutive months of decline. And in China, where the company is facing its fiercest competition from brands like BYD and Zeekr, second quarter sales were down 12 percent year over year — though there were some hints of a possible comeback in recent weeks. In the US, Tesla's response is the pull out all the stops. To start, every Tesla vehicle is eligible for the $7,500 federal EV tax credit until September 30th, when the incentive sunsets thanks to President Trump's budget bill. On top of that, Tesla is also offering one free month of Full Self-Driving (Supervised) driver assist feature, as well as a free trial of its Premium Connectivity package (one month for Model 3 and Y, and one year for Model S, X, and Cybertruck). And there's also a $1,000 discount for 'American heroes' like members of the military, teachers, and first responders. Moreover, all models except the Cybertruck are eligible for a free upgrade for a limited time. And the Model 3 and Cybertruck come with 0 percent APR financing with a purchase of the FSD package. And the Model 3 also comes with 18 months of free Supercharging for cash purchases. Meanwhile, Model Y buyers with 'excellent credit' and a 15 percent down payment can get 3.49 percent APR financing, down from 5.54 percent. Cybertruck buyers of a similar status can also get 0 percent APR, as well as a free 20-inch 'Cyber wheel' upgrade, which typically have a $3,500 value. And for anyone interested in the company's practically ancient Model S or X (though they did just get a mild refresh), Tesla is offering a free upgrade when you purchase the FSD feature. The third quarter is likely going to be a high water mark for Tesla, giving the expiring federal incentives and an expectation that EV prices will be going up across the board. Tesla has tried to juice sales by refreshing its models with new designs and a mild tech upgrade, but Elon Musk's polarizing persona has made it increasingly difficult for the company to climb out of its rut. And the newest model, the Cybertruck, is just a sales dud and arguably one of the biggest automotive flop in decades — no one wants it. Of course, Tesla could reverse its fortunes with the release of a new, more affordable EV — not just a cheaper Model 3 or Y. The company has been promising a cheaper model for years now, though Musk has said he's more interested in pushing robotaxis and humanoid robots than spending resources on a budget EV. The CEO recently teased an 'epic demo' of a new Tesla project by the end of the year. The company is expected to report another steep drop in profits in its Q2 earnings on Wednesday, July 23rd.
